Lucyd, Inc (LUCY) vs Sonoma Pharmaceuticals, Inc. (SNOA)

A side-by-side comparison of Lucyd, Inc and Sonoma Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — LUCY vs SNOA

growth of $100 · dividends reinvested · last 4y
LUCY -99.2% (-70.5%/yr)SNOA -98.1% (-63.1%/yr)SNOA compounded faster over this window
020406080100Start $1002023202420252026$1$2
LUCY SNOA

LUCY vs SNOA: by the numbers

  • •SNOA is the larger company ($6M vs $6M market cap).
  • •Both run net losses; SNOA's is the smaller (-10.33% vs -225.28% net margin).
  • •LUCY grew revenue faster over the past five years (64.52% vs 5.79% CAGR).

Metrics side by side

Valuation

MetricLUCYSNOA
P/S ratio1.690.26
P/B ratio0.840.88

Profitability

MetricLUCYSNOA
Gross margin22.79%38.91%
Operating margin-319.16%-6.41%
Net margin-225.28%-10.33%
ROE-111.42%-34.33%
ROIC-122.15%-10.98%

Growth (annualized)

MetricLUCYSNOA
Revenue CAGR (5Y)64.52%5.79%
Total return CAGR (5Y)N/A-59.29%

Frequently asked

Which has grown faster, LUCY or SNOA?
Over the past five years, LUCY grew revenue faster — LUCY at a 64.52% CAGR versus SNOA at 5.79%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.